Fevertree Drinks PLC 

Fevertree Drinks PLC (LSE: FEVR) is a UK-based company specializing in premium carbonated mixers listed on the FTSE AIM UK 50 Index of the London Stock Exchange. Its product lineup features a wide array of offerings, including Premium Indian Tonic Water, flavored tonics, ginger ales, ginger beers, colas, lemonades, sodas, adult soft drinks, and cocktail mixers. Notable products include Margarita Mixer, Espresso Martini, Mojito Mixer, Elderflower Tonic Water, Mediterranean Tonic Water, Premium Soda Water, Raspberry & Orange Blossom Soda, Mexican Lime Soda, Ginger Beer, Ginger Ale, Spiced Orange Ginger Ale, and Sicilian Lemonade. The company operates across multiple key markets, including the United Kingdom, the United States, Europe, and other international regions.

Key Recommendation Rationale – Sell at GBX 860.73

• Resistance near Current levels: FEVR’s stock price crossed the Resistance (R1) which was stated in the previous report on 21 March 2025 therefore, there could be a possibility that the stock might consolidate or decline from the current levels, considering overstretched valuation. Considering the market conditions and the price action, it is prudent to exit from the stock.
• Muted Revenue Growth Amid Market Share Gains: Fevertree delivered a modest 3% year-on-year revenue growth at constant currency in FY24, which is relatively underwhelming given its continued expansion efforts and market share gains, especially in the US. This sluggish top-line performance reflects the ongoing impact of a challenging macroeconomic backdrop, with inflationary pressures dampening discretionary spending and restraining overall category growth.
• Weak Inventory Efficiency Driving Cash Flow Strain: Fevertree’s inventory turnover ratio of 4.1x lags the industry median of 4.4x, indicating slower inventory movement. This, combined with a bloated cash conversion cycle of 134.7 days (more than double the industry median of 62.6 days), highlights operational inefficiencies in working capital management—tying up cash in stock and delaying cash inflows, despite strong reported liquidity.

Valuation Methodology: Price/ Earnings Approach

Share Price Chart  

One-Year Technical Price Chart (as of May 13, 2025). Source: REFINITIV, Analysis: Kalkine Group

Conclusion

Fevertree posted FY24 revenue of £111.1 million, reflecting a 3% year-on-year increase, driven by a 7% rise from its Tree brand. However, the overall performance was impacted by external factors, including a challenging macroeconomic environment and inflationary pressures that dampened overall category growth. The company’s operational inefficiencies are highlighted by its inventory turnover ratio of 4.1x, below the industry median of 4.4x, and a cash conversion cycle of 134.7 days, which is more than double the industry median of 62.6 days. These inefficiencies are tying up cash in stock and delaying cash inflows, despite strong reported liquidity. FEVR appears overvalued. For conducting the valuation, the following peers have been considered: Nichols PLC (LSE: NICL), Diageo PLC (LSE: DGE), etc

Given its current trading levels, the recent strategic investments and partnerships, relative valuation, and associated risks, it is prudent to exit the stock at the current levels. Hence, a ‘Sell’ recommendation is given on the stock at the Current Market Price of GBX 860.73 as of 13 May 2025, 11:01 AM, GMT+1.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 13 May 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’